GEV vs TMO: Which Is the Better Buy?
Side-by-side comparison of GE Vernova Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-24.
GE Vernova Inc. · Industrials
$951.82
+35.4% upside to fair value
Med Conviction
Grade B
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$658.32
+31.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
GEV has more upside to fair value
(+35.4%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
GEV |
TMO |
| Current Price |
$951.82 |
$658.32 |
| Fair Value Estimate |
$1,288.67 |
$863.34 |
| Upside to Fair Value |
+35.4%
|
+31.1%
|
| Market Cap |
$253.5B |
$244.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
28.2x
|
25.9x
|
| Price / Sales |
6.1x
|
5.3x
|
| Price / FCF |
20.5x
|
33.4x
|
| Revenue Growth YoY |
+21.9%
|
+10.5%
|
| Gross Margin |
20.2%
|
40.4%
|
| Operating Margin |
4.4%
|
17.7%
|
| Return on Equity |
83.4%
|
13.4%
|
| Dividend Yield |
0.18% |
0.28% |
| FCF Yield |
4.88%
|
3.0%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
GE Vernova is an energy equipment and infrastructure enterprise spanning Power (gas, nuclear, hydro, steam), Wind (offshore and onshore turbines), and Electrification (grid, power conversion, solar and storage), with 78,000 employees and a Cambridge, Massachusetts headquarters. The business quality is high on the strength of an installed base that generates roughly 25% of the world's electricity,…
Thermo Fisher Scientific is a global life-sciences and laboratory-services platform spanning Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services, with recognized brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Patheon, and PPD, serving pharmaceutical, biotech, clinical, academic, and governme…
Accumulation Zones
| Metric |
GEV |
TMO |
| Zone Low |
$966.50 |
$647.50 |
| Zone High |
$1,095.37 |
$733.84 |
| In Buy Zone? |
Yes
|
Yes
|